Actual status of AIDS-related lymphoma management in Japan.
Nagai
Hirokazu
H
Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan. nagaih@nnh.hosp.go.jp.
Iwasaki
Nami
N
Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, 460-0001, Japan.
Odawara
Takashi
T
The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Okada
Seiji
S
Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007564:Japan / Q000453:epidemiology; D016483:Lymphoma, AIDS-Related / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000628:therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab